Literature DB >> 25852008

Long-chain acylcarnitines activate cell stress and myokine release in C2C12 myotubes: calcium-dependent and -independent effects.

Colin S McCoin1, Trina A Knotts2, Kikumi D Ono-Moore3, Pieter J Oort3, Sean H Adams4.   

Abstract

Acylcarnitines, important lipid biomarkers reflective of acyl-CoA status, are metabolites that possess bioactive and inflammatory properties. This study examined the potential for long-chain acylcarnitines to activate cellular inflammatory, stress, and death pathways in a skeletal muscle model. Differentiated C2C12 myotubes treated with l-C14, C16, C18, and C18:1 carnitine displayed dose-dependent increases in IL-6 production with a concomitant rise in markers of cell permeability and death, which was not observed for shorter chain lengths. l-C16 carnitine, used as a representative long-chain acylcarnitine at initial extracellular concentrations ≥25 μM, increased IL-6 production 4.1-, 14.9-, and 31.4-fold over vehicle at 25, 50, and 100 μM. Additionally, l-C16 carnitine activated c-Jun NH2-terminal kinase, extracellular signal-regulated kinase, and p38 mitogen-activated protein kinase between 2.5- and 11-fold and induced cell injury and death within 6 h with modest activation of the apoptotic caspase-3 protein. l-C16 carnitine rapidly increased intracellular calcium, most clearly by 10 μM, implicating calcium as a potential mechanism for some activities of long-chain acylcarnitines. The intracellular calcium chelator BAPTA-AM blunted l-C16 carnitine-mediated IL-6 production by >65%. However, BAPTA-AM did not attenuate cell permeability and death responses, indicating that these outcomes are calcium independent. The 16-carbon zwitterionic compound amidosulfobetaine-16 qualitatively mimicked the l-C16 carnitine-associated cell stress outcomes, suggesting that the effects of high experimental concentrations of long-chain acylcarnitines are through membrane disruption. Herein, a model is proposed in which acylcarnitine cell membrane interactions take place along a spectrum of cellular concentrations encountered in physiological-to-pathophysiological conditions, thus regulating function of membrane-based systems and impacting cell biology.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  cell death; interleukin-6; skeletal muscle

Mesh:

Substances:

Year:  2015        PMID: 25852008      PMCID: PMC4451287          DOI: 10.1152/ajpendo.00602.2014

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  43 in total

1.  Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.

Authors:  Timothy R Koves; John R Ussher; Robert C Noland; Dorothy Slentz; Merrie Mosedale; Olga Ilkayeva; James Bain; Robert Stevens; Jason R B Dyck; Christopher B Newgard; Gary D Lopaschuk; Deborah M Muoio
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

Review 2.  Assembly and localization of Toll-like receptor signalling complexes.

Authors:  Nicholas J Gay; Martyn F Symmons; Monique Gangloff; Clare E Bryant
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

3.  Influence of acylcarnitines of different chain length on pure and mixed phospholipid vesicles and on sarcoplasmic reticulum vesicles.

Authors:  P Haeyaert; A Verdonck; F H Van Cauwelaert
Journal:  Chem Phys Lipids       Date:  1987-10       Impact factor: 3.329

Review 4.  Lipotoxic diseases.

Authors:  Roger H Unger
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

Review 5.  Lipotoxic endoplasmic reticulum stress, β cell failure, and type 2 diabetes mellitus.

Authors:  Trevor J Biden; Ebru Boslem; Kwan Yi Chu; Nancy Sue
Journal:  Trends Endocrinol Metab       Date:  2014-03-18       Impact factor: 12.015

6.  Palmitoyl carnitine modifies sodium currents and induces transient inward current in ventricular myocytes.

Authors:  J Wu; P B Corr
Journal:  Am J Physiol       Date:  1994-03

7.  Inhibition of gap junctional conductance by long-chain acylcarnitines and their preferential accumulation in junctional sarcolemma during hypoxia.

Authors:  J Wu; J McHowat; J E Saffitz; K A Yamada; P B Corr
Journal:  Circ Res       Date:  1993-04       Impact factor: 17.367

8.  Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.

Authors:  Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey
Journal:  J Nutr       Date:  2009-04-15       Impact factor: 4.798

9.  Intracellular calcium release is required for caspase-3 and -9 activation.

Authors:  Lee Tantral; Krishnamurthy Malathi; Shinya Kohyama; Michael Silane; Alejandro Berenstein; Thottala Jayaraman
Journal:  Cell Biochem Funct       Date:  2004 Jan-Feb       Impact factor: 3.685

10.  Endoplasmic reticulum stress and lipid metabolism: mechanisms and therapeutic potential.

Authors:  Sana Basseri; Richard C Austin
Journal:  Biochem Res Int       Date:  2011-12-13
View more
  19 in total

1.  Cellular energetics and mitochondrial uncoupling in canine aging.

Authors:  Justin W Nicholatos; Timothy M Robinette; Saurabh V P Tata; Jennifer D Yordy; Adam B Francisco; Michael Platov; Tiffany K Yeh; Olga R Ilkayeva; Frank K Huynh; Maxim Dokukin; Dmytro Volkov; Michael A Weinstein; Adam R Boyko; Richard A Miller; Igor Sokolov; Matthew D Hirschey; Sergiy Libert
Journal:  Geroscience       Date:  2019-04-01       Impact factor: 7.713

Review 2.  Metabolic pathways at the crossroads of diabetes and inborn errors.

Authors:  Eric S Goetzman; Zhenwei Gong; Manuel Schiff; Yan Wang; Radhika H Muzumdar
Journal:  J Inherit Metab Dis       Date:  2017-09-26       Impact factor: 4.982

3.  Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.

Authors:  Jie Zhang; Alan R Light; Charles L Hoppel; Caitlin Campbell; Carol J Chandler; Dustin J Burnett; Elaine C Souza; Gretchen A Casazza; Ronald W Hughen; Nancy L Keim; John W Newman; Gary R Hunter; Jose R Fernandez; W Timothy Garvey; Mary-Ellen Harper; Oliver Fiehn; Sean H Adams
Journal:  Exp Physiol       Date:  2016-12-12       Impact factor: 2.969

4.  Fine Mapping and Functional Analysis Reveal a Role of SLC22A1 in Acylcarnitine Transport.

Authors:  Hye In Kim; Johannes Raffler; Wenyun Lu; Jung-Jin Lee; Deepti Abbey; Danish Saleheen; Joshua D Rabinowitz; Michael J Bennett; Nicholas J Hand; Christopher Brown; Daniel J Rader
Journal:  Am J Hum Genet       Date:  2017-09-21       Impact factor: 11.025

5.  Differential diagnosis between hepatocellular carcinoma and cirrhosis by serum amino acids and acylcarnitines.

Authors:  Yong Zhang; Nan Ding; Yunfeng Cao; Zhitu Zhu; Peng Gao
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 6.  Developmental origins of NAFLD: a womb with a clue.

Authors:  Stephanie R Wesolowski; Karim C El Kasmi; Karen R Jonscher; Jacob E Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-10-26       Impact factor: 46.802

Review 7.  Acylcarnitines--old actors auditioning for new roles in metabolic physiology.

Authors:  Colin S McCoin; Trina A Knotts; Sean H Adams
Journal:  Nat Rev Endocrinol       Date:  2015-08-25       Impact factor: 43.330

Review 8.  Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling.

Authors:  Wynn G Hunter; Jacob P Kelly; Robert W McGarrah; William E Kraus; Svati H Shah
Journal:  Curr Heart Fail Rep       Date:  2016-06

9.  Advances in the Understanding and Treatment of Mitochondrial Fatty Acid Oxidation Disorders.

Authors:  Eric S Goetzman
Journal:  Curr Genet Med Rep       Date:  2017-07-25

10.  A single bout of cycling exercise induces nucleosome repositioning in the skeletal muscle of lean and overweight/obese individuals.

Authors:  Prasad P Devarshi; Andrea S Pereyra; Jessica M Ellis; Tara M Henagan
Journal:  Diabetes Obes Metab       Date:  2021-09-20       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.